Ironwood Pharmaceuticals
(NASDAQ:IRWD)
$8.71
0.09[1.04%]
At close: Mar 28
$8.71
0[0.00%]
After Hours: 4:02PM EDT
Consensus Rating1
Overweight
Highest Price Target1
$22.00
Lowest Price Target1
$13.00
Consensus Price Target1
$17.50

Ironwood Pharmaceuticals Stock (NASDAQ:IRWD), Analyst Ratings, Price Targets, Predictions

Ironwood Pharmaceuticals Inc has a consensus price target of $17.5, established from looking at the 10 latest analyst ratings. The last 3 analyst ratings were released from Wells Fargo, Piper Sandler, and Craig-Hallum on March 1, 2024, February 16, 2024, and January 17, 2024. With an average price target of $18.67 between Wells Fargo, Piper Sandler, and Craig-Hallum, there's an implied 114.31% upside for Ironwood Pharmaceuticals Inc from these 3 analyst ratings.

Analyst Rating Summary1

Analyst Ratings
Dec 23
1
Jan
1
Feb
1
Mar
1
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Wells Fargo
Piper Sandler
Craig-Hallum
JMP Securities
Wells Fargo

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for Ironwood Pharmaceuticals

date
ticker
Buy Now
Company
Current price
Upside/Downside
Analyst Firm
Analyst & % Accurate
Price Target Change
Rating Change
Previous / Current Rating
Get Alert
03/01/2024IRWDBuy Now
Ironwood Pharmaceuticals
$8.7160.73%Wells Fargo
Mohit Bansal
$20 → $14MaintainsOverweightGet Alert
02/16/2024IRWDBuy Now
Ironwood Pharmaceuticals
$8.71141.1%Piper Sandler
David Amsellem
$20 → $21MaintainsOverweightGet Alert
01/17/2024IRWDBuy Now
Ironwood Pharmaceuticals
$8.71141.1%Craig-Hallum
Chase Knickerbocker
→ $21Initiates → BuyGet Alert
12/14/2023IRWDBuy Now
Ironwood Pharmaceuticals
$8.71129.62%Wells Fargo
Mohit Bansal
→ $20Initiates → OverweightGet Alert
09/28/2023IRWDBuy Now
Ironwood Pharmaceuticals
$8.71152.58%JMP Securities
Jason Butler
→ $22Initiates → Market OutperformGet Alert
05/23/2023IRWDBuy Now
Ironwood Pharmaceuticals
$8.71118.14%Piper Sandler
David Amsellem
$16 → $19MaintainsOverweightGet Alert
08/16/2022IRWDBuy Now
Ironwood Pharmaceuticals
$8.7149.25%Wells Fargo
Jacob Hughes
$12 → $13MaintainsEqual-WeightGet Alert
04/22/2022IRWDBuy Now
Ironwood Pharmaceuticals
$8.7183.7%Piper Sandler
David Amsellem
→ $16Initiates → OverweightGet Alert
10/12/2021IRWDBuy Now
Ironwood Pharmaceuticals
$8.7160.73%Morgan Stanley
David Lebowitz
MaintainsEqual-WeightGet Alert
07/16/2021IRWDBuy Now
Ironwood Pharmaceuticals
$8.7137.77%Morgan Stanley
David Lebowitz
MaintainsEqual-WeightGet Alert

FAQ

Q

What is the target price for Ironwood Pharmaceuticals (IRWD)?

A

The latest price target for Ironwood Pharmaceuticals (NASDAQ: IRWD) was reported by Wells Fargo on March 1, 2024. The analyst firm set a price target for $14.00 expecting IRWD to rise to within 12 months (a possible 60.73% upside). 6 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Ironwood Pharmaceuticals (IRWD)?

A

The latest analyst rating for Ironwood Pharmaceuticals (NASDAQ: IRWD) was provided by Wells Fargo, and Ironwood Pharmaceuticals maintained their overweight rating.

Q

When was the last upgrade for Ironwood Pharmaceuticals (IRWD)?

A

There is no last upgrade for Ironwood Pharmaceuticals.

Q

When was the last downgrade for Ironwood Pharmaceuticals (IRWD)?

A

There is no last downgrade for Ironwood Pharmaceuticals.

Q

When is the next analyst rating going to be posted or updated for Ironwood Pharmaceuticals (IRWD)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Ironwood Pharmaceuticals, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Ironwood Pharmaceuticals was filed on March 1, 2024 so you should expect the next rating to be made available sometime around March 1, 2025.

Q

Is the Analyst Rating Ironwood Pharmaceuticals (IRWD) correct?

A

While ratings are subjective and will change, the latest Ironwood Pharmaceuticals (IRWD) rating was a maintained with a price target of $20.00 to $14.00. The current price Ironwood Pharmaceuticals (IRWD) is trading at is $8.71, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch